We are live on ! Find out more
FMI

F/M Investments Portfolio holdings

AUM $1.97B
1-Year Est. Return 30.33%
This Fund
S&P 500
This Quarter Est. Return
-2.84%
1 Year Est. Return
+30.33%
3 Year Est. Return
+101.46%
5 Year Est. Return
+144.03%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
Cap. Flow
-$78.6M
Cap. Flow %
-3.13%
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31

Top Buys

Rank Stock Value
1
IDXX icon
Idexx Laboratories
IDXX
+$11.8M
2
C icon
Citigroup
C
+$6.42M
3
BLK icon
Blackrock
BLK
+$5.5M
4
HUBS icon
HubSpot
HUBS
+$4.88M
5
LRCX icon
Lam Research
LRCX
+$4.71M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$18.7M
2
ZTWO icon
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
+$18.5M
3
AAPL icon
Apple
AAPL
+$10.2M
4
TFC icon
Truist Financial
TFC
+$9.55M
5
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
+$6.55M

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 11.09%
3 Financials 10.98%
4 Consumer Discretionary 8.01%
5 Industrials 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VO icon
51
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$10.2M 0.41%
158,728
+5,768
+4% +$387K
MS icon
52
Morgan Stanley
MS
$339B
$10.1M 0.4%
86,270
-5,803
-6% -$748K
PNC icon
53
PNC Financial Services
PNC
$101B
$10M 0.4%
57,064
-8,900
-13% -$1.68M
SYK icon
54
Stryker
SYK
$130B
$9.87M 0.39%
26,526
-1,275
-5% -$485K
ULTA icon
55
Ulta Beauty
ULTA
$23.9B
$9.77M 0.39%
26,649
-412
-2% -$157K
ETN icon
56
Eaton
ETN
$175B
$9.71M 0.39%
35,699
-2,124
-6% -$661K
VOO icon
57
Vanguard S&P 500 ETF
VOO
$1.01T
$9.7M 0.39%
18,881
+56
+0.3% +$30.3K
MDT icon
58
Medtronic
MDT
$110B
$9.56M 0.38%
106,393
-3,287
-3% -$294K
J icon
59
Jacobs Solutions
J
$17.1B
$9.41M 0.37%
78,582
-379
-0.5% -$48.8K
TMO icon
60
Thermo Fisher Scientific
TMO
$217B
$9.11M 0.36%
18,308
-1,799
-9% -$974K
NVO
61
Novo Nordisk
NVO
$207B
$8.96M 0.36%
128,984
-1,382
-1% -$114K
NEE icon
62
NextEra Energy
NEE
$178B
$8.86M 0.35%
124,966
-5,352
-4% -$378K
MET icon
63
MetLife
MET
$62.2B
$8.77M 0.35%
109,169
-3,178
-3% -$264K
PPL
64
PPL Corp
PPL
$26.7B
$8.71M 0.35%
241,329
-6,346
-3% -$215K
ISRG icon
65
Intuitive Surgical
ISRG
$134B
$8.52M 0.34%
17,200
-3,226
-16% -$1.78M
TSN icon
66
Tyson Foods
TSN
$20.5B
$8.49M 0.34%
133,056
+12,618
+10% +$741K
SPY icon
67
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$8.42M 0.34%
15,057
+227
+2% +$133K
TSLA icon
68
Tesla
TSLA
$1.29T
$7.87M 0.31%
30,369
-15,475
-34% -$5.16M
IJR icon
69
iShares Core S&P Small-Cap ETF
IJR
$112B
$7.66M 0.31%
73,260
-12
-0% -$1.35K
MMSI icon
70
Merit Medical Systems
MMSI
$5.3B
$7.61M 0.3%
72,008
+1,051
+1% +$108K
VEU icon
71
Vanguard FTSE All-World ex-US ETF
VEU
$68.4B
$7.51M 0.3%
123,736
+1,585
+1% +$95.5K
BX icon
72
Blackstone
BX
$110B
$7.32M 0.29%
52,362
-611
-1% -$99.2K
PLMR icon
73
Palomar
PLMR
$3.55B
$7.06M 0.28%
51,476
-757
-1% -$89.7K
PWR icon
74
Quanta Services
PWR
$101B
$6.8M 0.27%
26,746
-1,638
-6% -$473K
OLLI icon
75
Ollie's Bargain Outlet
OLLI
$4.86B
$6.72M 0.27%
57,727
-888
-2% -$93.9K
1 2
3
4 5

Similar funds

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return

F/M Investments's Q1 2025 Portfolio in Review

As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.

  • F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
  • F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
  • F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
  • F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
  • F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
  • F/M Investments opened 23 new positions and closed 31 in Q1 2025.
  • F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.

Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.